Evidence map›Paper›PMID 26137224›Full record

ArticleBiomedical reports2015

Effects of high-fat diet on 1,2-dimethylhydrazine-induced aberrant crypt foci and colorectal tumours in rats.

Guangying Qi, B O Tang, Lihua Zhou, Hiroshi Jikihara, Atsumi Kiwata, Yuki Sakamoto, Fang Tang, Shengjun Xiao, Zhenran Wang, Qiuhui Wu and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Biomedical reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. The Potential Chemopreventive Effect ofInternational journal of molecular sciences · 2023
    Article
  2. Article
  3. Djulis (Nutrients · 2019
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Guangying QiDepartment of Pathology and Physiopathology, Guilin Medical University, Guilin, Guangxi 541004, P.R. China ; Department of Health Sciences, Faculty of Human Culture and Science, Prefectural University of Hiroshima, Hiroshima 734-8558, Japan.
B O TangDepartment of Hepatobiliary and Gastrointestinal Surgery, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi 541001, P.R. China.
Lihua ZhouDepartment of Pathology and Physiopathology, Guilin Medical University, Guilin, Guangxi 541004, P.R. China ; Department of Health Sciences, Faculty of Human Culture and Science, Prefectural University of Hiroshima, Hiroshima 734-8558, Japan.
Hiroshi JikiharaDepartment of Health Sciences, Faculty of Human Culture and Science, Prefectural University of Hiroshima, Hiroshima 734-8558, Japan.
Atsumi KiwataDepartment of Health Sciences, Faculty of Human Culture and Science, Prefectural University of Hiroshima, Hiroshima 734-8558, Japan.
Yuki SakamotoDepartment of Health Sciences, Faculty of Human Culture and Science, Prefectural University of Hiroshima, Hiroshima 734-8558, Japan.
Fang TangDepartment of Pathology and Physiopathology, Guilin Medical University, Guilin, Guangxi 541004, P.R. China.
Shengjun XiaoDepartment of Pathology and Physiopathology, Guilin Medical University, Guilin, Guangxi 541004, P.R. China.
Zhenran WangDepartment of Hepatobiliary and Gastrointestinal Surgery, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi 541001, P.R. China.
Qiuhui WuDepartment of Pathology and Physiopathology, Guilin Medical University, Guilin, Guangxi 541004, P.R. China.
Huiling LuDepartment of Pathology and Physiopathology, Guilin Medical University, Guilin, Guangxi 541004, P.R. China.
Zhen WuDepartment of Pathology and Physiopathology, Guilin Medical University, Guilin, Guangxi 541004, P.R. China.
Sien ZengDepartment of Pathology and Physiopathology, Guilin Medical University, Guilin, Guangxi 541004, P.R. China.
Fumio ShimamotoDepartment of Health Sciences, Faculty of Human Culture and Science, Prefectural University of Hiroshima, Hiroshima 734-8558, Japan.
Guilin Medical University · CNPrefectural University of Hiroshima · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity is one of the leading causes of numerous types of cancer. The present study investigated the impact of a high-fat diet on 1,2-dimethylhydrazine (DMH)-induced colorectal cancer (CRC) in F344 rats. A total of 16 male F344 rats aged 4 weeks were randomly divided into two groups (8 rats/group). Rats in group A were fed a basal diet with a moderate fat (MF) content, while rats in group B were fed a high-fat diet. Upon reaching 5 weeks of age, the rats were injected subcutaneously with DMH (20 mg/kg body weight). DMH was administered once a week for 8 consecutive weeks. All the rats were sacrificed 34 weeks after the first DMH injection and dissected to obtain samples of colorectal tissues. The tissues were examined under a microscope for the presence of aberrant crypt foci (ACFs) and subjected to histopathological analysis. The results showed that at the end of the 34-week experiment, body weights and visceral fat levels were significantly higher in the high-fat diet group compared to the basal diet group. In addition, the incidences of colorectal ACF, adenoma and adenocarcinoma were markedly elevated in the high-fat diet group compared to the basal diet group. These results indicate that the consumption of a high-fat diet promotes the development and progression of CRC and the control of fat intake may prevent CRC.

Indexed as

antitumourcolorectal cancerF344 ratshigh-fat diet

Identifiers

PMID26137224
PMCPMC4467215
OpenAlexW2111443922

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.